PFIZER INC (NYSE:PFE)

Headlines for PFIZER INC

Pfizer Must Pay $6.3 Million in Damages Over Prempro
Bloomberg - 8 hours ago
By Sophia Pearson and Jef Feeley Nov. 20 (Bloomberg) -- Two Pfizer Inc. units' hormone- replacement therapy drugs caused an Illinois woman's breast cancer, making them liable for at least $6.3 ...
Direction Of Health Overhaul Helps US Drug Stocks >MRK PFE
Wall Street Journal - 9 hours ago
By Peter Loftus Of DOW JONES NEWSWIRES Several US pharmaceutical stocks rose Friday as Pfizer Inc. (PFE) and Merck & Co. (MRK) hit 52-week highs, partly due to increasing investor comfort that a ...
Pfizer's Geodon gets expanded FDA approval
MSN Money - 12 hours ago
NEW YORK (AP) - Pfizer Inc. said Friday the Food and Drug Administration approved Geodon as a part of a combination maintenance treatment for bipolar disorder in adults. The new approval covers ...
Pfizer Receives FDA Approval For Geodon? (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults - Business Wire
Administration - Pfizer Receives FDA Approval For Geodon® (Ziprasidone HCI) Capsules For The Adjunctive Maintenance Treatment Of Bipolar Disorder In Adults - Ad-Hoc-News
RTT News - Trading Markets - Baltimore Sun
New 52-Week High Stocks (NLST, PFE, TRA, SJM, DBRN)
Benzinga - 13 hours ago
Netlist, Inc. (NASDAQ: NLST) hits a new 52-week high at $7.80 in today's morning trade. Currently NLST is trading at $7.42, up 31%. In the past one month, the stock is up over 1090%. Pfizer Inc ...